Agile Therapeutics to Present at Biotech Showcase 2017
December 22, 2016 08:00 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Dec. 22, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) announced today that its Chief Executive Officer, Al Altomari will present at the Biotech Showcase 2017 on...
Agile Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference
December 22, 2016 07:30 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Dec. 22, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company, announced today that its Chief Executive Officer, Al...
Agile Therapeutics Receives Approximately $3 Million in Non-Dilutive Funding from New Jersey’s Technology Business Tax Certificate Transfer Program
December 01, 2016 08:00 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Dec. 01, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company announced today that it has received net proceeds of...
Agile Therapeutics Reports Third Quarter 2016 Financial Results and Announces Completion of Subject Visits for Twirla® Phase 3 SECURE Clinical Trial
November 07, 2016 16:10 ET
|
Agile Therapeutics, Inc.
Top-Line Data Expected in Early January 2017; Resubmission Planned for First Half 2017 Cash Expected to Fund Operations Through the End of 2017 PRINCETON, N.J., Nov. 07, 2016 (GLOBE...
Agile Therapeutics Announces Plans to Advance Contraceptive Pipeline
July 12, 2016 16:12 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., July 12, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics Strengthens Executive Leadership Team with New Chief Commercial Officer
July 06, 2016 16:15 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., July 06, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of...
Agile Therapeutics to Present at the William Blair & Company’s 36th Annual Growth Stock Conference
June 07, 2016 08:00 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., June 07, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics to Present at the Jefferies 2016 Healthcare Conference
June 02, 2016 17:16 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., June 02, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics to Present at the 28th Annual ROTH Conference
March 03, 2016 16:15 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 03, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of new...
Appeals Court Rules Against EWTN in HHS Mandate Case
February 18, 2016 17:20 ET
|
EWTN Global Catholic Network
Irondale, AL, Feb. 18, 2016 (GLOBE NEWSWIRE) -- This afternoon, the 11th Circuit U.S. Court of Appeals in Atlanta ruled against EWTN Global Catholic Network in its long-running battle against...